The correlation between SNHG18 expression and MM prognosis was discovered according to multiple criteria, including International Staging System (ISS) classification, Revised International Staging System (R-ISS) classification, Mayo Clinic Risk Stratification for Multiple Myeloma (mSMART), and other standards for multiple myeloma classification. This evidence concerns the gene SNHG18 and Miyoshi myopathy.